Clik here to view.
Now we have a clue just how close Valeant came to the brink
We thought we would just circle back to Wednesday's Valeant Pharmaceuticals hearing in the US Senate to pull out a very important, and candid, quote from billionaire investor and board member, Bill...
View ArticleClik here to view.
The disastrous Valeant document everyone's been waiting for is finally here
After months of delays, a Senate hearing, and a precipitous stock fall, Valeant Pharmaceuticals finally filed its annual 10-K report to the Securities and Exchange Commission on Friday morning.The...
View ArticleClik here to view.
Valeant's outgoing CEO made an insane amount of money last year
Valeant Pharmaceuticals' outgoing CEO Michael Pearson made $143.1 million in 2015, according to Dow Jones.It was the year the international giant was brought to its knees.In October accusations of...
View ArticleClik here to view.
BILL ACKMAN: 'Of course' I regret Valeant
Activist investor Bill Ackman says "of course" he regrets investing in Valeant, the former stock market darling that has been hit with SEC investigations, Senate investigations, and a precipitous...
View ArticleClik here to view.
Bill Ackman had another terrible day
Bill Ackman probably did not have a happy end to his work week.Two of his biggest trades — Herbalife and Valeant Pharmaceuticals — headed in the opposite directions of his positions on...
View ArticleClik here to view.
Here's the email Bill Ackman sent to Charlie Munger to complain about...
The Senate has published a bunch of documents pertaining to Valeant, and it is a gold mine of info.We're running through the 818-page document and will be pulling out some of the highlights.First up,...
View ArticleClik here to view.
We just got insight into what Bill Ackman wants Valeant to do next
Activist hedge fund manager Bill Ackman has some thoughts on what Valeant should do next.He recently urged the former CEO of Valeant to go public with plans to IPO part of its subsidiary, Bausch &...
View ArticleClik here to view.
'The company is at risk of getting into a death spiral': Bill Ackman's emails...
The US Senate has released 818 pages of Valeant-related information connected to the investigation into the pharmaceutical company's business practices.Along with a variety of emails and documents, the...
View ArticleClik here to view.
A key figure in Bill Ackman's Valeant investment is leaving Pershing Square
William Doyle is leaving Pershing Square.Pershing just posted a letter to shareholders running through the fund's investments, revealing that Doyle would be leaving.Doyle, who attended Harvard Business...
View ArticleClik here to view.
One ugly chart shows how Bill Ackman's investments were decimated
Pershing Square just posted a first-quarter letter to shareholders running through the hedge fund's investments.The fund and its founder, Bill Ackman, had a torrid start to the year.It seemed as if...
View ArticleClik here to view.
Here's why it's so hard for the government to bust Herbalife
For the past three years, activist investor Bill Ackman has criticized the nutritional supplement company Herbalife to anyone who will listen — and on April 27, his audience happened to be a group of...
View ArticleClik here to view.
This has been the worst year for Wall Street's 'bros' in a long time
The "bros" on Wall Street are having a rough 2016.Now by "bros," I don't mean former frat boys still clinging to their cargo shorts despite the salary afforded to them by their grown-up job at...
View ArticleClik here to view.
Valeant just had to tell Wall Street about its new cataclysmic problem
Valeant Pharmaceuticals on Tuesday morning reported a Q1 earnings loss of $373.7 million, or $1.08 a share. It also cut guidance for the rest of the year. The stock has fallen 16% in Tuesday's trading...
View ArticleClik here to view.
Carl Icahn kicks Bill Ackman while he's down
Things were obviously getting a little too boring around Wall Street for Carl Icahn.The billionaire investor and founder of Icahn Enterprises decided on Thursday to dredge up one of his old feuds.He...
View ArticleClik here to view.
Bill Ackman's terrible bet on Valeant could have been avoided (vrx)
Hedge fund managers are usually considered the smartest investors in the game, but even the best sometimes make bad bets. Bill Ackman of Pershing Square Capital Management is one such hedge fund...
View ArticleClik here to view.
A big insurance firm was just downgraded because of Lynn Tilton
Standard & Poor's has cut MBIA Insurance's credit rating from B to CCC on fears that it will have to pay a $700 million claim for one of Patriarch Partners CEO Lynn Tilton's credit funds.Since last...
View ArticleClik here to view.
REPORT: Bill Ackman has fired some staff members
Bill Ackman's hedge fund has laid off eight lower-level staffers, The Wall Street Journal's David Benoit just reported, citing people familiar with the matter.The cuts, mostly of back-office workers,...
View ArticleClik here to view.
Forget Wimbledon — Wall Street's best tennis players are taking on Europe's...
Some of the biggest names in finance from both sides of the Atlantic will face off against each other at tennis in London this weekend.The Wimbledon finals may be making all the headlines, but people...
View ArticleClik here to view.
The best tennis players from Wall Street and the City of London took each...
Last weekend was a huge deal for tennis — and not just because Andy Murray won a second Wimbledon title.The second Finance Cup, an intense battle between the best tennis players on Wall Street (USA)...
View ArticleClik here to view.
Turns out nobody ever really wanted Bill Ackman at Valeant
Things could have been much different for Valeant Pharmaceuticals if former CEO Michael Pearson had stuck to his original guns about hedge fund billionaire Bill Ackman.Apparently, Pearson didn't want...
View Article